Aarti Industries FY26 Results: Revenue up 12%, EBITDA rises 15% on volume growth

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights
  • Consolidated revenue grew 12% YoY to ₹9,018 crore in FY26
  • EBITDA rose 15% to ₹1,172 crore; net profit up 27% to ₹419 crore
  • Volume growth exceeded 30% despite margin pressures from competition
  • Signed $150mn agrochemical supply deal and ₹200-250cr backward integration pact
  • Debt-to-equity ratio increased to 0.74 due to working capital needs
powered bylight_fuzz_icon
51543021

*this image is generated using AI for illustrative purposes only.

Aarti Industries reported a 12% year-on-year increase in consolidated revenue to ₹9,018 crore for FY26, driven by over 30% volume growth across key value chains. EBITDA expanded 15% to ₹1,172 crore, while net profit rose 27% to ₹419 crore compared to the previous fiscal year.

The specialty chemicals manufacturer navigated a volatile macro environment marked by US tariff announcements and geopolitical conflicts. Despite these headwinds, the company secured long-term supply contracts and executed backward integration projects to strengthen its market position.

Financial Performance

The company’s financial results for FY26 reflect robust top-line growth supported by higher asset utilization in Nitro Chloro Benzenes (NCB), Di-Chlorobenzenes (DCB), and MMA segments.

Metric FY25 FY26 Change
Revenue ₹8,046 crore ₹9,018 crore +12%
EBITDA ₹1,016 crore ₹1,172 crore +15%
Net Profit ₹331 crore ₹419 crore +27%
Capex ₹1,372 crore ₹1,125 crore -18%

Net fixed assets stood at ₹6,399 crore, a marginal increase from ₹6,377 crore in FY25. The debt-to-equity ratio rose to 0.74 from 0.62, attributed to increased working capital requirements due to rising raw material prices amid West Asia conflicts.

What the Numbers Show

Revenue growth significantly outpaced EBITDA expansion, indicating margin compression during the period. While volumes grew over 30%, the company faced continued margin pressure from competitive landscapes and input cost inflation. Additionally, net profit benefited from exceptional items, including ₹29 crore from favorable IT appeal rulings, partially offset by ₹22 crore in one-off write-offs related to new labor code impacts.

Operational Highlights

Capacity utilization improved across major product groups:

  • NCB utilization reached 86% (up 9% YoY)
  • DCB utilization hit 80% (up 9% YoY)
  • MMA/Fuel Additives utilization stood at 86% with capacity scaled up to 360 kTPA in Q1FY27

Energy applications contributed 43% of total revenue, up from 36% in FY25, driven by favorable blending economics and expanded capacities in US and EMEA regions. Agrochemicals remained stable at 18% share, though margins stayed under pressure.

Strategic Developments

In March 2026, Aarti Industries entered into a material amendment for an exclusive backward integration contract with a global chemical major. This involves an investment of ₹200–250 crore over two years to manufacture feedstock currently supplied by the customer, aiming to optimize opex and freight over a 15-year period.

The company also signed a $150 million multi-year supply agreement with a global agrochemical innovator until March 2030. This contract supports higher capacity utilization without significant capex, with volume growth expected from FY27.

Sustainability & Outlook

Aarti Industries achieved a Platinum rating from EcoVadis in June 2026, placing it in the top 1% of global chemical companies. Renewable energy contribution exceeded 21% of total power purchased, with plans to reach 70% by end-FY27.

Near-term EBITDA growth drivers include cost optimization initiatives targeting ₹150–200 crore savings and volume ramp-ups expected to contribute ₹350–550 crore. Key projects like Zone IV and joint ventures with Augene and Re Aarti are slated for commissioning in FY27.

Historical Stock Returns for Aarti Industries

1 Day5 Days1 Month6 Months1 Year5 Years
+1.76%+1.44%-5.72%+15.45%+27.86%0.0%

How will the 15-year backward integration contract with the global chemical major impact Aarti Industries' long-term EBITDA margins and operational flexibility?

What specific strategies is Aarti Industries employing to mitigate margin compression in the agrochemicals segment amid persistent input cost inflation?

Will the commissioning of Zone IV and joint ventures with Augene and Re Aarti in FY27 be sufficient to offset the working capital strain indicated by the rising debt-to-equity ratio?

Aarti Industries appoints Suyog Kotecha as MD; Rajendra Gogri steps down

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights
  • Suyog Kotecha appointed as Managing Director and CEO effective October 1, 2026
  • Rajendra V. Gogri transitions to Non-Executive Chairman role
  • Shareholders adopted FY26 financial statements and declared dividend
  • Focus for FY27 includes asset utilization improvement and Zone IV commercialization
  • Remote e-voting conducted with M/s. BNP & Associates as scrutinizer
powered bylight_fuzz_icon
51542784

*this image is generated using AI for illustrative purposes only.

Aarti Industries shareholders approved the appointment of Suyog Kotecha as Managing Director and CEO, effective October 1, 2026. The company also adopted its annual financial statements for the year ended March 31, 2026, during its 43rd Annual General Meeting held on September 21, 2026.

The meeting, conducted via Video Conferencing and Other Audio Visual Means in compliance with Ministry of Corporate Affairs and SEBI circulars, saw all board members and auditors present. A requisite quorum was established to begin proceedings.

Governance Changes

Rajendra V. Gogri, Rashesh C. Gogri, and Renil R. Gogri will transition from executive roles to Non-Executive Directors on the Board. Rajendra V. Gogri will continue as Non-Executive Chairman. This leadership shift marks a transition to professional executive management under Suyog Kotecha, while promoter stewardship remains intact.

The Board expressed full confidence in Kotecha’s strategic clarity and execution capabilities. The company emphasized that its core values of Care, Integrity, and Excellence would continue to guide operations.

Strategic Outlook

Suyog Kotecha outlined focus areas for FY27, including improving asset utilization, commercializing Zone IV, and scaling high-growth niches. He highlighted the importance of expanding advanced chemistries and strengthening customer partnerships.

The company aims to improve capital efficiency and generate stronger free cash flows. Kotecha noted that global manufacturing networks are being redrawn, with customers prioritizing reliability, sustainability, and supply chain resilience over cost alone.

Meeting Resolutions

Shareholders approved several ordinary and special business items during the AGM.

Category Resolution Details
Ordinary Adoption of Annual Financial Statements for year ended March 31, 2026
Ordinary Declaration of Dividend for year ended March 31, 2026
Ordinary Re-appointment of Ajay Kumar Gupta and Suyog K. Kotecha by rotation
Special Re-appointment of Rashesh C. Gogri as Non-Executive Director w.e.f. October 1, 2026
Special Appointment of Suyog K. Kotecha as Managing Director for five years w.e.f. October 1, 2026
Special Approval of Cost Auditors' remuneration for FY27

Remote e-voting was conducted between September 18 and September 20, 2026. M/s. BNP & Associates served as the scrutinizer for the voting process. Results were to be declared within two working days of the meeting's conclusion.

Historical Stock Returns for Aarti Industries

1 Day5 Days1 Month6 Months1 Year5 Years
+1.76%+1.44%-5.72%+15.45%+27.86%0.0%

How is the transition to professional executive management under Suyog Kotecha expected to impact Aarti Industries' operational agility and decision-making speed compared to the previous promoter-led model?

What specific timelines and capital expenditures are anticipated for the commercialization of Zone IV, and how might this affect the company's near-term revenue growth trajectory?

In light of the global shift toward supply chain resilience over cost efficiency, how does Aarti Industries plan to differentiate its advanced chemistry offerings to secure long-term contracts with key customers?

More News on Aarti Industries

1 Year Returns:+27.86%